<?xml version="1.0" encoding="UTF-8"?>
<!-- JLSitemap 2025-11-05 09:06:58 -->
<?xml-stylesheet type="text/xsl" href="https://keyslides.accmed.org/sitemap_urlset.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.w3.org/1999/xhtml http://www.w3.org/2002/08/xhtml/xhtml1-strict.xsd" xhtml="http://www.w3.org/1999/xhtml"><url><loc>https://keyslides.accmed.org/</loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc>https://keyslides.accmed.org/aa-vv</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-10-06T15:17:32+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/adriano-venditti</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:25:06+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/alberto-sobrero</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-07-10T14:33:48+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/alessandra-tedeschi</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:13:03+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/alessandro-isidori</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:10:06+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/alessandro-pastorino</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-07-18T12:36:43+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/andrea-ardizzoni</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:33:43+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/andrea-necchi</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:29:52+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/antonio-cuneo</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:21:39+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/armando-orlandi</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:19:16+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/armando-santoro</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T14:54:27+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/best-from</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2024-08-02T09:33:41+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/board</loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc>https://keyslides.accmed.org/breast</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-03-11T10:57:16+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/101:sabcs-2018</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:24:46+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/104:l-anticorpo-coniugato-ds-8201-nel-carcinoma-mammario-her2-positivo</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:24:23+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/112:monaleesa-7</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:23:30+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/123:il-trattamento-chemioterapico-nella-paziente-anziana-con-carcinoma-mammario-metastatico</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2024-06-27T15:14:20+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/128:il-trattamento-dell-early-breast-cancer-her2-nel-2020</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:19:31+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/129:san-antonio-breast-cancer-symposium-2019</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:19:16+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/136:asco-2020-breast-cancer</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:14:34+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/144:tucatinib-nel-trattamento-del-tumore-mammario</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:10:41+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/145:san-antonio-breast-cancer-symposium-2020</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:10:23+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/152:esmo-2021-breast-cancer</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-11-03T13:19:02+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/154:san-antonio-breast-cancer-symposium-2021</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2022-07-18T12:28:09+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/159:trastuzumab-deruxtecan-le-evidenze-cliniche-aggiornate-nel-carcinoma-mammario</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2022-07-18T14:37:50+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/163:interazioni-farmacologiche-di-abemaciclib-dalla-teoria-alla-pratica</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2022-09-13T07:47:38+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/165:sacituzumab-govitecan-attualita-terapeutiche-e-prospettive-future</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2023-01-17T09:02:26+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/166:san-antonio-breast-cancer-symposium-2022</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2023-02-13T11:12:01+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/177:il-carcinoma-mammario-evidenze-ragionate-da-chicago-2023</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2023-11-17T14:07:38+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/180:trastuzumab-deruxtecan-le-evidenze-cliniche-aggiornate-nel-carcinoma-mammario</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2023-12-18T16:23:16+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/189:capivasertib-evidenze-cliniche-nel-carcinoma-mammario</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2024-06-27T15:11:53+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/195:her2-ultralow-breast-cancer-new-molecular-subtype-new-plans</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-03-11T10:57:16+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/21:sabcs-2013-san-antonio-breast-cancer-symposium</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:39:01+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/24:esmo-ecco-estro-2013</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:38:14+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/25:asco-2013-breast-cancer</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:36:38+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/26:sabcs-2012-san-antonio-breast-cancer-symposium</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:37:50+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/27:esmo-2012-breast-cancer</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:37:33+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/29:prognosi-e-trattamento-adiuvante-del-carcinoma-mammario-di-piccole-dimensioni</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:37:07+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/30:everolimus-nel-carcinoma-mammario-metastatico-hr-her2</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T09:17:22+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/33:ebcc-8-european-breast-cancer-conference</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:35:39+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/35:sabcs-2011-san-antonio-breast-cancer-symposium</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:35:05+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/39:bolero-2-news</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:34:19+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/41:ebcc-2014-european-breast-cancer-conference</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:33:55+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/46:carcinoma-mammario-metastatico-her2-le-sequenze-terapeutiche</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T09:07:57+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/47:esmo-2014-breast-cancer</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:33:16+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/48:trastuzumab-emtansine-t-dm1-nel-carcinoma-mammario-metastatico-her2</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:33:04+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/49:san-antonio-breast-cancer-symposium-2014</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:32:50+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/55:asco-2015-breast-cancer</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:31:41+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/61:ecc-2015-breast-cancer</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:31:02+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/66:san-antonio-breast-cancer-symposium-2015</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2024-06-27T15:14:29+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/70:asco-2016-breast-cancer</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:30:15+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/77:san-antonio-breast-cancer-symposium-2016</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:28:17+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/81:asco-2017-breast-cancer</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:27:48+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/91:sabcs-2017</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:26:58+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/92:abemaciclib-nel-trattamento-del-carcinoma-mammario-er-her2</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:26:47+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/breast/item/96:best-from-esmo-2018-breast-cancer</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:26:03+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/bruno-daniele</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:27:10+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/camillo-porta</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2024-03-07T11:00:01+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/carlo-finelli</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:16:28+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/carmen-criscitiello</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:14:34+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/chiara-bennati</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2022-12-21T10:54:11+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/chiara-cremolini</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:23:46+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/chronicles-and-commentaries?commentaries=</loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc>https://keyslides.accmed.org/cinzia-ortega</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:32:21+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/claudia-caserta</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2024-06-06T15:07:33+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/cora-n-sternberg</loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc>https://keyslides.accmed.org/davide-melisi</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2022-07-28T08:28:18+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/descrizione-del-sito</loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc>https://keyslides.accmed.org/diego-cortinovis</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2024-11-25T16:33:30+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/domenica-lorusso</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2022-03-31T12:19:18+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/elena-rosa-fumagalli</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-03-19T14:34:11+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/elena-verzoni</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2023-05-04T12:38:58+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/evaristo-maiello</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:38:36+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/expert-tips?commentaries=</loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc>https://keyslides.accmed.org/fabio-puglisi</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-11-03T13:19:02+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/filippo-montemurro</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:39:01+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/filippo-pietrantonio</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2024-03-06T16:49:37+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/francesca-romana-mauro</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:19:46+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/francesco-bertoldo</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:34:50+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/francesco-grossi</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:27:35+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-10-30T08:48:53+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/106:world-congress-on-gastrointestinal-cancer-2018</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:24:03+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/108:asco-2019-colorectal-cancer</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:23:46+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/122:attualita-terapeutiche-nel-trattamento-del-carcinoma-del-pancreas</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:21:06+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/140:nuovi-approcci-alle-terapie-dei-tumori-delle-vie-biliari</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:13:39+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/160:aggiornamenti-terapeutici-nel-trattamento-del-colangiocarcinoma</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2022-07-28T08:28:18+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/173:chicago-2023-colorectal-cancers</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2023-07-17T12:40:32+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/175:raccomandazioni-cliniche-per-il-trattamento-dei-gist-sulla-base-delle-linee-guida-di-esmo-euracan-genturis</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2023-08-30T13:58:51+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/179:ripretinib-nel-trattamento-dei-gist</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2023-12-05T10:21:27+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/182:evidenze-consolidate-e-prospettive-future-nel-trattamento-del-colon-retto-metastatico-con-cetuximab</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2024-03-06T16:49:37+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/192:linee-guida-aiom-2024-raccomandazioni-cliniche-per-il-trattamento-dei-gist</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-03-19T14:34:11+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/196:san-francisco-talks-riflessioni-sui-principali-risultati-presentati-ad-asco-gi-2025</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-07-10T14:28:55+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/202:chicago-talks-riflessioni-sui-principali-risultati-presentati-ad-asco-2025-parte-iii</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-07-10T14:33:48+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/203:durvalumab-aggiornamenti-e-nuovi-dati-di-efficacia-per-hcc-stomaco-e-vie-biliari</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-07-18T12:36:43+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/205:trastuzumab-deruxtecan-nel-carcinoma-gastroesofageo-le-evidenze-cliniche-aggiornate</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-10-30T08:48:53+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/23:regorafenib-nel-trattamento-del-carcinoma-del-colon-retto-metastatico</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:38:36+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/45:il-carcinoma-del-colon-retto-metastatico-evidenze-scientifiche-2014</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-03-21T10:47:33+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/56:la-terapia-medica-del-carcinoma-del-pancreas-non-piu-una-patologia-orfana</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T08:58:45+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/63:il-carcinoma-del-colon-retto-metastatico-evidenze-scientifiche-2015</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T08:55:41+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/64:sorafenib-nell-epatocarcinoma-l-appropriatezza-dell-indicazione</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T08:54:35+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/68:stato-dell-arte-del-trattamento-dei-gist</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T08:48:19+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/71:asco-2016-gastrointestinal-cancer</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:30:04+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/76:cetuximab-quanto-e-importante-la-localizzazione-del-tumore</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:28:47+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/78:attualita-terapeutiche-nel-carcinoma-del-colon-retto-metastatico</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:28:04+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/79:il-carcinoma-del-colon-retto-metastatico-valutazione-della-risposta-alla-terapia</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T08:40:38+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/83:asco-2017-colorectal-cancer</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T13:38:19+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/85:il-carcinoma-del-pancreas-around-surgery</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T08:35:00+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/88:il-carcinoma-del-colon-retto-metastatico-le-evidenze-scientifiche-emerse-nel-2017</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:27:23+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/89:la-terapia-dell-epatocarcinoma-la-forza-delle-evidenze</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:27:10+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gi/item/97:world-congress-on-gastrointestinal-cancer-2018</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:25:48+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/giampaolo-bianchini</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2023-12-18T16:23:16+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/giuseppe-aprile</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:30:04+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/giuseppe-curigliano</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-03-11T10:57:16+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/giuseppe-procopio</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:37:21+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/grazia-arpino</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:31:41+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-07-10T14:28:40+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/102:la-pratica-clinica-nel-trattamento-della-recidiva-del-carcinoma-ovarico-parte-3</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:24:35+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/121:il-continuum-della-salute-muscolo-scheletrica-nel-carcinoma-della-prostata</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:21:16+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/125:niraparib-nel-trattamento-del-carcinoma-ovarico</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:20:12+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/126:il-carcinoma-della-prostata-evidenze-scientifiche-2019</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:20:00+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/142:nuovi-approcci-target-nel-carcinoma-prostatico</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:11:10+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/150:il-trattamento-del-carcinoma-renale-dagli-studi-clinici-alla-real-world-evidence</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-13T14:48:39+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/156:nuove-opzioni-terapeutiche-nel-carcinoma-dell-endometrio</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2022-03-31T12:19:18+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/168:asco-gu-2023-focus-sul-carcinoma-renale</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2023-05-04T12:38:58+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/172:chicago-2023-genitourinary-cancers</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2023-07-17T12:40:45+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/176:la-radio-ligand-therapy-nel-tumore-alla-prostata-avanzato-e-metastatico-resistente-alla-castrazione-e-psma-positivo</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2023-09-27T14:07:36+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/184:avelumab-le-evidenze-cliniche-aggiornate-nel-carcinoma-uroteliale</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2024-03-07T11:09:22+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/185:avelumab-le-evidenze-cliniche-aggiornate-nel-carcinoma-uroteliale</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2024-06-06T15:07:33+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/198:san-francisco-talks-riflessioni-sui-principali-risultati-presentati-ad-asco-gu-2025</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-07-10T14:28:40+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/199:roma-talks-riflessioni-sui-principali-risultati-presentati-ad-esgo-2025</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-07-10T14:27:50+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/22:asco-gu-2014-genitourinary-cancers-symposium</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:38:48+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/28:esmo-2012-renal-cell-carcinoma</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:37:21+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/32:il-trattamento-chemioterapico-del-carcinoma-ovarico</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:35:51+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/34:prostate-cancer-crpc-therapeutic-options-and-bone-metastasis-management</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T09:15:18+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/44:asco-2014-genitourinary-cancer</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:33:32+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/51:il-mito-all-asco</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:32:38+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/52:i-nuovi-radiofarmaci-nel-trattamento-del-carcinoma-prostatico</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:32:21+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/53:asco-2015-genitourinary-cancer</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:32:09+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/54:asco-2015-gynecological-cancer</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:31:58+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/57:ecc-2015-gynecological-cancer</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:31:29+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/59:ruolo-dell-angiogenesi-nel-carcinoma-della-cervice-uterina</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:31:15+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/65:esgo-2015</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T08:53:14+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/67:l-algoritmo-terapeutico-nel-carcinoma-ovarico</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-03-21T10:46:05+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/69:asco-2016-gynecological-and-genitourinary-cancers</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:30:26+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/72:carcinoma-della-vescica-scelte-terapeutiche</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:29:52+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/75:igcs-2016</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T08:42:58+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/84:asco-2017-gynecological-cancer</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T08:35:51+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/86:argomenti-selezionati-da-siog-2017-il-carcinoma-ovarico</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T08:34:12+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/87:argomenti-selezionati-da-siog-2017-carcinoma-dell-endometrio-e-della-cervice</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T08:33:26+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/90:best-from-esgo-2017</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T08:31:24+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/93:nuove-opzioni-terapeutiche-a-bersaglio-molecolare-per-il-carcinoma-del-rene-avanzato-cabozantinib</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:26:36+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/94:asco-2018</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:26:25+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/95:la-pratica-clinica-nel-trattamento-della-recidiva-del-carcinoma-ovarico</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:26:14+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/gu/item/99:la-pratica-clinica-nel-trattamento-della-recidiva-del-carcinoma-ovarico-parte-2</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:25:16+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/laura-biganzoli</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2024-06-27T15:14:29+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/lectures</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-10-30T08:48:53+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/lorenzo-antonuzzo</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:24:03+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/lorenzo-fornaro</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-10-30T08:48:53+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/lucia-del-mastro</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:37:07+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/lung</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-10-06T15:17:32+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/lung/item/111:terapia-ssclc-2019</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T08:21:17+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/lung/item/133:chemioradioterapia-e-immunoterapia-di-mantenimento-nuovo-standard-terapeutico-nei-pazienti-affetti-da-nsclc-in-stadio-iii-non-resecabile</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T08:01:25+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/lung/item/148:nsclc-avanzato-e-nuovi-target-molecolari-emergenti-braf-ret-met-ntrk</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T14:55:10+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/lung/item/162:cemiplimab-nel-trattamento-di-prima-linea-nel-nsclc-avanzato-con-espressione-di-pd-l1-50</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2022-09-22T10:25:31+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/lung/item/164:osimertinib-nel-trattamento-dei-pazienti-con-nsclc-con-mutazione-di-egfr</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2022-12-21T10:54:11+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/lung/item/181:combinazione-di-cemiplimab-e-chemioterapia-nel-trattamento-di-prima-linea-del-nsclc-avanzato</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2024-02-01T11:47:52+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/lung/item/191:chicago-2024-lung-cancer</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2024-08-02T09:33:41+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/lung/item/194:cemiplimab-continuum-of-care-nel-paziente-con-nsclc-wt-e-livelli-di-espressione-di-pd-l1-1</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2024-11-25T16:33:30+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/lung/item/204:barcellona-talks-riflessioni-sui-principali-risultati-presentati-ad-wclc-2025</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-10-06T15:17:32+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/lung/item/42:asco-2014-lung-cancer</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:33:43+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/lung/item/73:esmo-2016-lung-cancer</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:29:15+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/lung/item/82:asco-2017-lung-cancer</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:27:35+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/marco-maruzzo</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-13T14:48:39+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/marco-montillo</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:14:48+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/maria-abbondanza-pantaleo</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2023-12-05T10:21:27+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/maria-teresa-voso</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:21:28+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/mario-scartozzi</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2023-07-17T12:40:32+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/massimo-bernardi</loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc>https://keyslides.accmed.org/massimo-breccia</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:14:09+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/massimo-dimaio</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-07-10T14:03:27+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/matteo-lambertini</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2023-01-17T09:02:26+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/mib</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-10-06T15:17:32+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/michelino-de-laurentiis</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:23:30+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-07-10T14:27:20+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/117:il-carcinoma-cutaneo-a-cellule-squamose</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-03-21T10:45:11+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/120:esmo-2019</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T08:18:00+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/143:trastuzumab-deruxtecan-le-evidenze-cliniche-aggiornate</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:10:54+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/149:gli-anticorpi-monoclonali-coniugati-anti-her3</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:32:18+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/155:i-molecular-tumor-board</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2022-03-31T10:26:40+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/169:chronicles-commentaries-chicago-2023</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2023-09-27T15:08:13+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/171:chronicles-commentaries-chicago-2023-part-2</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2023-09-27T15:08:04+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/178:chronicles-commentaries-madrid-2023</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2023-11-17T14:34:45+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/186:anticorpi-farmaco-coniugati-adc-nei-tumori-solidi</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2024-06-03T10:46:10+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/187:chronicles-commentaries-chicago-2024-part-1</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2024-06-19T15:17:26+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/188:chronicles-commentaries-chicago-2024-part-2</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2024-06-27T10:26:56+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/190:datopotomab-deruxtecan-le-evidenze-cliniche-aggiornate</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2024-07-26T14:40:28+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/193:chronicles-commentaries-barcellona-2024</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2024-10-01T08:21:49+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/197:tislelizumab-le-evidenze-cliniche-aggiornate</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-03-25T15:40:11+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/200:chicago-talks-riflessioni-sui-principali-risultati-presentati-ad-asco-2025</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-07-10T14:27:20+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/201:chicago-talks-riflessioni-sui-principali-risultati-presentati-ad-asco-2025-parte-ii</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-07-10T14:03:27+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/31:asco-annual-meeting-2012</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:36:03+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/36:la-bone-health-nel-paziente-neoplastico</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:34:50+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/37:asco-annual-meeting-2010</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:34:36+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/38:targeting-pi3k-akt-mtor</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T09:12:19+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/40:i-nuovi-farmaci-in-oncologia-in-italia</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-03-19T15:07:24+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/50:highlights-from-grandangolo-2014-un-anno-di-oncologia</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T09:05:30+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/62:la-medicina-di-precisione-il-caso-del-melanoma-metastatico</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T08:56:32+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/74:immunoterapia-gli-inibitori-dei-checkpoint-immuni</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:28:58+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/miscellanea/item/98:esmo-2018</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:25:36+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/monica-galli</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:15:03+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/monica-niger</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:13:39+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/nello-martini</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-03-19T15:07:24+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/nicoletta-colombo</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:31:29+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2023-08-03T14:54:33+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia/item/100:ash-2018-acute-myeloid-leukemia</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:25:06+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia/item/113:eha-2019-focus-sulle-patologie-linfoidi</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:21:39+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia/item/114:eha-2019-focus-sulle-patologie-mieloidi</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:21:28+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia/item/124:il-ruolo-di-lenalidomide-nei-linfomi</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:20:30+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia/item/127:ash-2019-focus-sulle-leucemie-linfatiche</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:19:46+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia/item/130:ash-2019-focus-sulle-patologie-mieloidi</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:16:28+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia/item/131:linfoma-di-hodgkin-focus-sul-trattamento</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T08:02:14+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia/item/132:le-sindromi-mielodisplastiche-con-sideroblasti-ad-anello</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:16:12+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia/item/134:ash-2019-focus-sul-mieloma-multiplo</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:15:03+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia/item/135:come-evolve-il-paradigma-terapeutico-della-leucemia-linfatica-cronica</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:14:48+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia/item/137:aggiornamenti-terapeutici-nel-dlbcl-relapsed-refractory</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:14:22+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia/item/138:attualita-terapeutiche-nella-leucemia-mieloide-cronica</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:14:09+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia/item/139:analisi-farmacologica-comparata-degli-inibitori-di-flt3</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:13:56+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia/item/141:la-macroglobulinemia-di-waldenstroem</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:13:03+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia/item/146:attualita-terapeutiche-nella-leucemia-mieloide-acuta-recidivante-o-refrattaria</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:10:06+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia/item/147:i-car-t-nel-2021</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T14:54:27+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia/item/151:analisi-comparata-degli-inibitori-di-btk-focus-su-zanubrutinib</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-30T08:44:38+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia/item/153:acalabrutinib-nel-trattamento-della-leucemia-linfatica-cronica</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2022-01-13T15:53:47+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia/item/157:gli-inibitori-di-terza-generazione-nel-trattamento-della-leucemia-acuta-linfoblastica-philadelphia-positiva</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2022-06-20T11:03:55+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia/item/158:personalizzazione-della-terapia-per-il-paziente-con-leucemia-mieloide-cronica-ricaduto-o-intollerante-a-tki-di-seconda-generazione</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2022-07-06T12:05:25+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia/item/161:b-cell-malignancies-hot-news-from-eha-2022</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2022-08-01T08:44:43+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia/item/167:ash-2022-focus-on-lymphoma-cll</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2023-02-09T16:12:40+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/onco-ematologia/item/174:tafasitamab-nel-trattamento-del-linfoma-diffuso-a-grandi-cellule-b</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2023-08-03T14:54:33+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/orazio-caffo</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:20:00+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/paolo-pronzato</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2025-07-10T14:27:20+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/pier-luigi-zinzani</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2023-02-09T16:12:40+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/presentazione-e-obiettivi</loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc>https://keyslides.accmed.org/roberto-latagliata</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:16:12+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/roberto-sabbatini</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:32:09+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/romano-danesi</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2022-01-13T15:53:47+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/sabino-de-placido</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:10:23+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/sandro-pignata</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:30:26+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/sara-lonardi</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:28:04+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/sara-pilotto</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2024-08-02T09:33:41+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/stefano-cascinu</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:21:06+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/stefano-cordio</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:25:48+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/tipi</loc><changefreq>weekly</changefreq><priority>0.5</priority></url><url><loc>https://keyslides.accmed.org/vanda-salutari</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2021-09-02T15:20:12+00:00</lastmod></url><url><loc>https://keyslides.accmed.org/veronica-prati</loc><changefreq>weekly</changefreq><priority>0.5</priority><lastmod>2024-03-07T11:09:22+00:00</lastmod></url></urlset>
